Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples